Rahem Rahmati: Toxic Epidermal Necrolysis in a Pregnant IVF Patient on Hydroxychloroquine
Rahem Rahmati, Executive Secretary at Student Research and Technology Committee, shared a post on LinkedIn about a paper published in Clinical Case Reports:
“A reminder that even established treatments can have rare, severe consequences.
Our latest case report details a pregnant IVF patient who developed life-threatening Toxic Epidermal Necrolysis (TEN) after taking hydroxychloroquine for recurrent implantation failure.
Title: Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy
Authors: Hatav Ghasemi Tehrani, Faezeh Zakerinasab, Negar Khalili Geshnigani, Rahem Rahmati, Nastaran Zamani Dehkordi
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 12, 2026, 12:56Vinnie Arvin Amir: New AI Study Explores Immune Factors in Pregnancy Loss
-
Mar 12, 2026, 12:53Deep Learning Bridges the Diagnostic Gap in Chronic Endometritis – Medicina MDPI
-
Mar 12, 2026, 12:49Explore the ASRM CELL Training Lab – ASRM
-
Mar 12, 2026, 02:28Anthony Griffiths to Discuss Multidisciplinary Approaches to Endometriosis Care – BSGI
-
Mar 11, 2026, 12:36Christopher Robinson: B-Lynch Uterine Compression Technique Discussed in AJOG Expert Review
-
Mar 11, 2026, 09:55Abstract Deadline and Early Registration Approaching for ESHRE Embryology 2026 – ESHRE
-
Mar 11, 2026, 08:57How Hyaluronic Acid Medium Improves Live Birth Rate? – RBMO
-
Mar 11, 2026, 08:46PCOS and Higher BMI Linked to Increased Risk of Type 2 Diabetes – Fertility and Sterility
-
Mar 11, 2026, 05:39Vikram Sinai Talaulikar: Learning Opportunities for Healthcare Professionals in Menopause Care
